Related Experiment Video

Updated: Dec 16, 2025

Quantification of Antibody-dependent Enhancement of the Zika Virus in Primary Human Cells
07:53

Quantification of Antibody-dependent Enhancement of the Zika Virus in Primary Human Cells

Published on: January 18, 2019

9.1K

Vaccine development during global epidemics: the Zika experience

Priscila M S Castanha1, Ernesto T A Marques1

  • 1Graduate School of Public Health, Department of Infectious Diseases and Microbiology, University of Pittsburgh, Pittsburgh, PA 15261, USA.

The Lancet. Infectious Diseases
|July 4, 2020
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Evaluation of Zika Virus-specific T-cell Responses in Immunoprivileged Organs of Infected Ifnar1-/- Mice
10:01

Evaluation of Zika Virus-specific T-cell Responses in Immunoprivileged Organs of Infected Ifnar1-/- Mice

Published on: October 17, 2018

8.4K
Rescue and Characterization of Recombinant Virus from a New World Zika Virus Infectious Clone
07:35

Rescue and Characterization of Recombinant Virus from a New World Zika Virus Infectious Clone

Published on: June 7, 2017

10.0K

Related Experiment Videos

Last Updated: Dec 16, 2025

Quantification of Antibody-dependent Enhancement of the Zika Virus in Primary Human Cells
07:53

Quantification of Antibody-dependent Enhancement of the Zika Virus in Primary Human Cells

Published on: January 18, 2019

9.1K
Evaluation of Zika Virus-specific T-cell Responses in Immunoprivileged Organs of Infected Ifnar1-/- Mice
10:01

Evaluation of Zika Virus-specific T-cell Responses in Immunoprivileged Organs of Infected Ifnar1-/- Mice

Published on: October 17, 2018

8.4K
Rescue and Characterization of Recombinant Virus from a New World Zika Virus Infectious Clone
07:35

Rescue and Characterization of Recombinant Virus from a New World Zika Virus Infectious Clone

Published on: June 7, 2017

10.0K

Related Concept Videos

Vaccinations01:51

Vaccinations

50.7K
Overview
50.7K
Cross-reactivity00:42

Cross-reactivity

32.6K
Overview
32.6K
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

387
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
387

Articles linked to this work by shared authors, journal, and citation graph.

SARS-CoV-2 Seroprevalence of Surinamese Children and Determinants of Seropositivity in the CCREOH/MeKiTamara Cohort.

Children (Basel, Switzerland)·2026

Host genetic ancestry and immunity to pathogens.

Trends in microbiology·2026

Long-term efficacy and safety of the single-dose tetravalent Butantan dengue vaccine.

Nature medicine·2026

Symptomatic chikungunya and chronic post-infection arthralgia in a highly endemic setting in Northeastern Brazil, 2018-2019: Clinical characteristics, prevalence and associated factors.

PloS one·2026

Zika Virus Neutralizing Antibody Responses Elicited by Vaccination or Infection.

Open forum infectious diseases·2025

New Insights into Host Genetic Ancestry as a Risk Factor for Dengue Disease.

DNA and cell biology·2025

Clinical, molecular, and in vitro evidence of artemisinin partial resistance in Ethiopian Plasmodium falciparum: a prospective, multisite, surveillance study.

The Lancet. Infectious diseases·2026

Efficacy, immunogenicity, and safety of the 9-valent human papillomavirus vaccine in males aged 16-26 years in Japan: a randomised, double-blind, placebo-controlled trial.

The Lancet. Infectious diseases·2026

A review of Bundibugyo virus and the 2026 outbreak: lessons for epidemic preparedness.

The Lancet. Infectious diseases·2026

Impact of directly observed treatment and extended age range of seasonal malaria chemoprevention with sulfadoxine-pyrimethamine plus amodiaquine in Burkina Faso: a three-group, open-label, cluster-randomised, controlled trial.

The Lancet. Infectious diseases·2026

Baloxavir marboxil, favipiravir, or oseltamivir in patients with non-severe symptomatic seasonal influenza (AD ASTRA): a phase 2, open-label, adaptive, randomised controlled trial.

The Lancet. Infectious diseases·2026

Effectiveness of scabies treatments in Italy (SCAB-net): a prospective observational study.

The Lancet. Infectious diseases·2026

The reverberations of famine: understanding the aftermath of the Holodomor, 1932-1933.

Journal of public health policy·2026

Perceived Efficacy and Acceptability of a Spatial Repellent for Malaria Control in Western Kenya: Lessons from a Qualitative Social Science Study Conducted in Conjunction with an Epidemiological Efficacy Trial.

The American journal of tropical medicine and hygiene·2026

Global Health in Radiology: Evolution, Challenges, and a Framework for the Future.

Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes·2026

Regional Statistics from 2023 Community-based Severe Trauma Surveillance in the Gyeongnam Region.

Public health weekly report·2026

Knowing better, doing better: Taking stock of the UN Agenda 2030, its means, its progress, and its shortfalls.

iScience·2026

Mapping stakeholders' positioning in the access and delivery partnership value chain: the case of the RTS,S malaria vaccine introduction in Ghana.

International journal of public health·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us